Brain Death clinical trials at University of California Health

• Intravenous Thyroxine for Heart-Eligible Organ Donors

  open to eligible people ages 14-55

  This randomized controlled trial will evaluate whether intravenous thyroxine infusion given to brain-dead organ donors who are eligible to donate hearts for 12 hours will result in more hearts transplanted than saline placebo

  at UCSD

• Deceased Organ Donor Interventions to Protect Kidney Graft Function

  Sorry, in progress, not accepting new patients

  To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.

  at UCSF

Last updated: November 22, 2021